BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35929507)

  • 1. Functional characteristics and research trends of PDE11A in human diseases (Review).
    Kong G; Lee H; Vo TT; Juang U; Kwon SH; Park J; Park J; Kim SH
    Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35929507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.
    Boikos SA; Horvath A; Heyerdahl S; Stein E; Robinson-White A; Bossis I; Bertherat J; Carney JA; Stratakis CA
    Horm Metab Res; 2008 May; 40(5):347-53. PubMed ID: 18491255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phosphodiesterase 11 (Pde11a) knockout mouse expressed functional but reduced Pde11a: Phenotype and impact on adrenocortical function.
    Levy I; Szarek E; Maria AG; Starrost M; De La Luz Sierra M; Faucz FR; Stratakis CA
    Mol Cell Endocrinol; 2021 Jan; 520():111071. PubMed ID: 33127481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.
    Kelly MP
    Adv Neurobiol; 2017; 17():201-230. PubMed ID: 28956334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A.
    Fawcett L; Baxendale R; Stacey P; McGrouther C; Harrow I; Soderling S; Hetman J; Beavo JA; Phillips SC
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3702-7. PubMed ID: 10725373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.
    Libé R; Fratticci A; Coste J; Tissier F; Horvath A; Ragazzon B; Rene-Corail F; Groussin L; Bertagna X; Raffin-Sanson ML; Stratakis CA; Bertherat J
    Clin Cancer Res; 2008 Jun; 14(12):4016-24. PubMed ID: 18559625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains.
    Yuasa K; Kanoh Y; Okumura K; Omori K
    Eur J Biochem; 2001 Jan; 268(1):168-78. PubMed ID: 11121118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
    Bimpaki EI; Nesterova M; Stratakis CA
    Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.
    Vezzosi D; Libé R; Baudry C; Rizk-Rabin M; Horvath A; Levy I; René-Corail F; Ragazzon B; Stratakis CA; Vandecasteele G; Bertherat J
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2063-9. PubMed ID: 22996146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.
    Libé R; Horvath A; Vezzosi D; Fratticci A; Coste J; Perlemoine K; Ragazzon B; Guillaud-Bataille M; Groussin L; Clauser E; Raffin-Sanson ML; Siegel J; Moran J; Drori-Herishanu L; Faucz FR; Lodish M; Nesterova M; Bertagna X; Bertherat J; Stratakis CA
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E208-14. PubMed ID: 21047926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing revealed PDE11A as a novel candidate gene for early-onset Alzheimer's disease.
    Qin W; Zhou A; Zuo X; Jia L; Li F; Wang Q; Li Y; Wei Y; Jin H; Cruchaga C; Benitez BA; Jia J
    Hum Mol Genet; 2021 May; 30(9):811-822. PubMed ID: 33835157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare inactivating PDE11A variants associated with testicular germ cell tumors.
    Pathak A; Stewart DR; Faucz FR; Xekouki P; Bass S; Vogt A; Zhang X; Boland J; Yeager M; Loud JT; Nathanson KL; McGlynn KA; Stratakis CA; Greene MH; Mirabello L
    Endocr Relat Cancer; 2015 Dec; 22(6):909-17. PubMed ID: 26459559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does phosphodiesterase 11A (PDE11A) hold promise as a future therapeutic target?
    Kelly MP
    Curr Pharm Des; 2015; 21(3):389-416. PubMed ID: 25159071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sleep Quality- and Myopia-Linked PDE11A-Y727C Variant Impacts Neural Physiology by Reducing Catalytic Activity and Altering Subcellular Compartmentalization of the Enzyme.
    Sbornova I; van der Sande E; Milosavljevic S; Amurrio E; Burbano SD; Das PK; Do HH; Fisher JL; Kargbo P; Patel J; Porcher L; De Zeeuw CI; Meester-Smoor MA; Winkelman BHJ; Klaver CCW; Pocivavsek A; Kelly MP
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression.
    Yuasa K; Kotera J; Fujishige K; Michibata H; Sasaki T; Omori K
    J Biol Chem; 2000 Oct; 275(40):31469-79. PubMed ID: 10906126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population.
    Horvath A; Giatzakis C; Robinson-White A; Boikos S; Levine E; Griffin K; Stein E; Kamvissi V; Soni P; Bossis I; de Herder W; Carney JA; Bertherat J; Gregersen PK; Remmers EF; Stratakis CA
    Cancer Res; 2006 Dec; 66(24):11571-5. PubMed ID: 17178847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity.
    Matthiesen K; Nielsen J
    Biochem J; 2009 Oct; 423(3):401-9. PubMed ID: 19689430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.
    Horvath A; Boikos S; Giatzakis C; Robinson-White A; Groussin L; Griffin KJ; Stein E; Levine E; Delimpasi G; Hsiao HP; Keil M; Heyerdahl S; Matyakhina L; Libè R; Fratticci A; Kirschner LS; Cramer K; Gaillard RC; Bertagna X; Carney JA; Bertherat J; Bossis I; Stratakis CA
    Nat Genet; 2006 Jul; 38(7):794-800. PubMed ID: 16767104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once upon a Testis: The Tale of Cyclic Nucleotide Phosphodiesterase in Testicular Cancers.
    Campolo F; Assenza MR; Venneri MA; Barbagallo F
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
    Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.